You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
加拿大终止与康希诺生物(06185.HK)新冠疫苗合作项目
阿思达克 08-27 11:10
加拿大国家研究委员会(NRC)表示,已经结束与康希诺生物(06185.HK)在研发新冠病毒疫苗的合作,因康希诺生物迟迟未取得运送疫苗的许可证。

康希诺生物5月同意将研发中的疫苗运往加拿大,与NRC合作进行疫苗测试。NRC发表声明称,由於康希诺生物目前并未获得授权运送疫苗,NRC的团队及研发设施将与其他公司进行合作。

康希诺生物行政总裁宇学峰较早时接受访问时表示,中国当局迟迟未能决定是否批准将疫苗运送到加拿大,一些政府部门不清楚疫苗是否应该进行全球测试又或者是如何进行。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account